Hello,
I’ve recently started exploring the Euronext Growth Milan market, which I consider one of Europe’s top micro-cap hunting grounds, alongside Poland. I’m about a third of the way through turning over sub-100M market caps that fit my industry criteria, and plan to wrap up my research within the next month or two. The goal is to visit the most promising companies this spring for on-the-ground due diligence.
So far, the most promising scuttlebutt candidate isn’t the cheapest stock, but it stands out as one of the more resilient niche businesses I’ve come across in recent years. When a friend asked me about it early on, I described it as “Leatt on steroids.” However, after digging deeper, I realized that comparison doesn’t do this company justice. Its market position is far stronger, and its industry is less competitive. Unlike Leatt, it’s completely off the Fintwit radar; in all of 2024, I found a grand total of four tweets mentioning the ticker. With bright years ahead, it’s time we put this gem on the map and take a deeper dive into…